Martine A Rothblatt - Net Worth and Insider Trading

Martine A Rothblatt Net Worth

The estimated net worth of Martine A Rothblatt is at least $18 Million dollars as of 2024-11-05. Martine A Rothblatt is the Chairperson & CEO of United Therapeutics Corp and owns about 45,892 shares of United Therapeutics Corp (UTHR) stock worth over $18 Million. Details can be seen in Martine A Rothblatt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martine A Rothblatt has not made any transactions after 2024-08-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Martine A Rothblatt

To

Martine A Rothblatt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Martine A Rothblatt owns 1 companies in total, including United Therapeutics Corp (UTHR) .

Click here to see the complete history of Martine A Rothblatt’s form 4 insider trades.

Insider Ownership Summary of Martine A Rothblatt

Ticker Comapny Transaction Date Type of Owner
UTHR United Therapeutics Corp 2024-08-26 director & Chief Executive Officer

Martine A Rothblatt Latest Holdings Summary

Martine A Rothblatt currently owns a total of 1 stock. Martine A Rothblatt owns 45,892 shares of United Therapeutics Corp (UTHR) as of August 26, 2024, with a value of $18 Million.

Latest Holdings of Martine A Rothblatt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UTHR United Therapeutics Corp 2024-08-26 45,892 382.77 17,566,081

Holding Weightings of Martine A Rothblatt


Martine A Rothblatt Form 4 Trading Tracker

According to the SEC Form 4 filings, Martine A Rothblatt has made a total of 154 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 154 sells. The most-recent trade in United Therapeutics Corp is the sale of 269 shares on August 26, 2024, which brought Martine A Rothblatt around $93,722.

Insider Trading History of Martine A Rothblatt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Martine A Rothblatt Trading Performance

GuruFocus tracks the stock performance after each of Martine A Rothblatt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martine A Rothblatt is 16.94%. GuruFocus also compares Martine A Rothblatt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martine A Rothblatt within 3 months outperforms 17 times out of 21 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Martine A Rothblatt's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Martine A Rothblatt

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
21 out of 21 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.91 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.42 LIMIT LIMIT LIMIT LIMIT LIMIT

Martine A Rothblatt Ownership Network

Ownership Network List of Martine A Rothblatt

No Data

Ownership Network Relation of Martine A Rothblatt

Insider Network Chart

Martine A Rothblatt Owned Company Details

What does United Therapeutics Corp do?

Who are the key executives at United Therapeutics Corp?

Martine A Rothblatt is the director & Chief Executive Officer of United Therapeutics Corp. Other key executives at United Therapeutics Corp include President and COO Michael Benkowitz , CFO and Treasurer James Edgemond , and EVP & General Counsel Paul A Mahon .

United Therapeutics Corp (UTHR) Insider Trades Summary

Over the past 18 months, Martine A Rothblatt made 64 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 707,954. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 128,500 shares made by Paul A Mahon , a net sale of 125,940 shares made by James Edgemond , and a net sale of 14,360 shares made by Christopher Causey .

In summary, during the past 3 months, insiders sold 186,469 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 186,469 shares. During the past 18 months, 1,062,383 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,062,383 shares.

United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

United Therapeutics Corp Insider Transactions

No Available Data

Martine A Rothblatt Mailing Address

Above is the net worth, insider trading, and ownership report for Martine A Rothblatt. Currently GuruFocus does not have mailing address information for Martine A Rothblatt.